[Successful treatment of the neuroleptic malignant syndrome using i.v. dantrolene sodium in the neurologic intensive care station].
The neuroleptic malignant syndrome (NMS) is one of the most dramatic psychiatric disorders every doctor in intensive care medicine can be confronted with. Two cases of successful treatment of NMS with intravenous application of dantrolene are presented. Although we used two very different doses, the treatment results were the same. Further studies will therefore be necessary to assess the optimal doses for this therapy.
Rechlin
T
T
Neurologische Universitätsklinik Erlangen.
Hilz
M J
MJ
Claus
D
D
D000328:Adult; D003422:Critical Care; D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*
D003620:Dantrolene
Erfolgreiche Behandlung des malignen neuroleptischen Syndroms mit Dantrolen-Natrium i.v. auf der neurologischen Intensivstation.